期刊文献+

基质金属蛋白酶-9的表达与肾细胞癌血管生成的关系 被引量:11

Relationship between Expression of Matrix Metalloproteinase-9 (MMP-9) and Angiogenesis in Renal Cell Carcinoma
下载PDF
导出
摘要 背景与目的:基质金属蛋白酶-9(matrixmetalloproteinase-9,MMP-9)与肿瘤的侵袭、转移密切相关,近年发现它与肿瘤的血管生成也有关。本研究旨在探讨MMP-9的表达与肾细胞癌血管生成的关系及其临床意义。方法:应用免疫组化SP法检测78例肾细胞癌组织中MMP-9、血管内皮细胞生长因子(vascularendothelialgrowthfactor,VEGF)的表达及微血管密度(microvesseldensity,MVD)。结果:MMP-9的表达与肾细胞癌的病理分期和组织学分级有关(P<0.05);MMP-9表达阳性组的MVD值为110.46±50.16,明显高于阴性组的MVD值(84.77±44.52)(P<0.05),亦明显高于对照组的MVD值(74.03±36.06)(P<0.01);肾细胞癌组织中MMP-9的表达水平与VEGF的表达呈显著性正相关(r=0.4096,P<0.01)。结论:MMP-9与肾细胞癌的血管生成有关,检测MMP-9的表达可作为反映肾细胞癌侵袭和转移潜能的生物学指标。 BACKGROUND & OBJECTIVE: Matrix metalloproteinase-9 (MMP-9) is closely related to tumor invasion and metastasis. It has been recently found tha t MMP-9 also plays a role in tumor angiogenesis. This study was designed to inv estigate the relationship between MMP-9 and angiogenesis in renal cell carcinom a (RCC) and its clinical significance. METHODS: SP immunohistochemistry was used to determine the expression of MMP-9, vascular endothelial growth factor (VEGF ), and microvessel density (MVD) in 78 RCC tissues. RESULTS: The expression of M MP-9 was related to the pathological stage and the histological grade in RCC (P < 0.05). The MVD value in MMP-9-positive group (110.46±50.16) was much higher than that in MMP-9-negative group (84.77±44.52)(P< 0.05). There was a po sitive correlation between the intensity of the expression of MMP-9 and that of VEGF in RCC tissues (r=0.4096,P< 0.01). MMP-9 and VEGF took synergistic effect on angiogenesis in RCC. CONCLUSION: MMP-9 is associated with angiogenesis in R CC, and can serve as a biomarker for the potentialities of invasion and metastas is of RCC.
出处 《癌症》 SCIE CAS CSCD 北大核心 2004年第3期326-329,共4页 Chinese Journal of Cancer
关键词 基质金属蛋白酶-9 MMP-9 肿瘤 基因表达 肾细胞癌 血管生成 免疫组织化学 Renal cell carcinoma (RCC) Matrix metalloproteinase-9 (MMP-9) An giogenesis Immunohistochemistry
  • 相关文献

参考文献9

  • 1南勋义,贺大林,党建功,陈兴发,王明珠,张冠军,张学斌.肾癌组织中VEGF、VEGFR、MVQ表达的临床意义[J].中华泌尿外科杂志,2001,22(5):267-268. 被引量:14
  • 2Begem G, Brekken R, McMahon G, et al. Marx metalloproteinase-9 triggers the angiogenic switch during carcinogenesis[J].Nature Cell Biology,2000,2(10):737—744.
  • 3Shimizu M,Saitoh Y,hoh H.Immunohistochemical staining of Ha-ras oncogene product in normal,benign and malignant human pancreatic tissues[J].Hum Pathol,1990,21(6):607—612.
  • 4Kugler A.Matrix metalloproteinases and their inhibitors[J].Anticancer Res,1999.19(2c):1589—1592.
  • 5Nelson AR,Fingleton B,Rothenberg ML,et al.Matrix metalloproteinases:biologic activity and clinical implications [J].Journal of Clinical Oncology,2000,18(5):1135—1149.
  • 6Kurizaki T, Toi M, Tominaga T. Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma [ J ]. Oncol Rep, 1998, 5 (3): 673-677.
  • 7Tolnay E, Wiethege T, Kuhned C, et al. Expression of type Ⅳ collagenase correlate with the expression of vascular endothelial growth factor in primary non-small cell lung cancer [J]. J Cancer Res Clin Oncol, 1997, 123(11-12): 652-658.
  • 8Riedel F, Gotte K, Schwalb J, et al. Expression of 92-kDa type Ⅳ collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma [J]. Int J Oncol, 2000, 17(6): 1099-1105.
  • 9Vu TH, Shipley JM, Bergers G, et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes [J]. Cell, 1998, 93 (3) : 411-422.

二级参考文献4

共引文献13

同被引文献35

引证文献11

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部